vs
Side-by-side financial comparison of HARROW, INC. (HROW) and Wingstop Inc. (WING). Click either name above to swap in a different company.
Wingstop Inc. is the larger business by last-quarter revenue ($183.7M vs $89.1M, roughly 2.1× HARROW, INC.). Wingstop Inc. runs the higher net margin — 16.3% vs 7.4%, a 8.8% gap on every dollar of revenue. On growth, HARROW, INC. posted the faster year-over-year revenue change (33.3% vs 7.4%). Over the past eight quarters, HARROW, INC.'s revenue compounded faster (60.5% CAGR vs 8.6%).
Harrow Health, Inc., formerly known as Imprimis Pharmaceuticals, is a publicly traded pharmaceutical company based in Nashville, Tennessee.
Wingstop Inc. is an American international fast food chain that primarily sells buffalo wings. Wingstop locations are decorated with a 1930s and 1940s pre-jet aviation theme.
HROW vs WING — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $89.1M | $183.7M |
| Net Profit | $6.6M | $29.9M |
| Gross Margin | 79.3% | 86.5% |
| Operating Margin | 17.5% | 27.4% |
| Net Margin | 7.4% | 16.3% |
| Revenue YoY | 33.3% | 7.4% |
| Net Profit YoY | -2.2% | — |
| EPS (diluted) | $0.20 | $1.08 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $183.7M | ||
| Q4 25 | $89.1M | $175.7M | ||
| Q3 25 | $71.6M | $175.7M | ||
| Q2 25 | $63.7M | $174.3M | ||
| Q1 25 | $47.8M | $171.1M | ||
| Q4 24 | $66.8M | $161.8M | ||
| Q3 24 | $49.3M | $162.5M | ||
| Q2 24 | $48.9M | $155.7M |
| Q1 26 | — | $29.9M | ||
| Q4 25 | $6.6M | $26.8M | ||
| Q3 25 | $1.0M | $28.5M | ||
| Q2 25 | $5.0M | $26.8M | ||
| Q1 25 | $-17.8M | $92.3M | ||
| Q4 24 | $6.8M | $26.8M | ||
| Q3 24 | $-4.2M | $25.7M | ||
| Q2 24 | $-6.5M | $27.5M |
| Q1 26 | — | 86.5% | ||
| Q4 25 | 79.3% | — | ||
| Q3 25 | 75.3% | — | ||
| Q2 25 | 74.5% | — | ||
| Q1 25 | 67.5% | — | ||
| Q4 24 | 78.8% | 85.6% | ||
| Q3 24 | 75.6% | 85.0% | ||
| Q2 24 | 74.4% | 85.4% |
| Q1 26 | — | 27.4% | ||
| Q4 25 | 17.5% | 26.7% | ||
| Q3 25 | 20.6% | 27.9% | ||
| Q2 25 | 17.9% | 25.9% | ||
| Q1 25 | -23.5% | 22.4% | ||
| Q4 24 | 19.3% | 25.9% | ||
| Q3 24 | 2.7% | 24.5% | ||
| Q2 24 | 3.1% | 26.5% |
| Q1 26 | — | 16.3% | ||
| Q4 25 | 7.4% | 15.2% | ||
| Q3 25 | 1.4% | 16.2% | ||
| Q2 25 | 7.8% | 15.4% | ||
| Q1 25 | -37.2% | 53.9% | ||
| Q4 24 | 10.1% | 16.5% | ||
| Q3 24 | -8.6% | 15.8% | ||
| Q2 24 | -13.2% | 17.7% |
| Q1 26 | — | $1.08 | ||
| Q4 25 | $0.20 | $0.99 | ||
| Q3 25 | $0.03 | $1.02 | ||
| Q2 25 | $0.13 | $0.96 | ||
| Q1 25 | $-0.50 | $3.24 | ||
| Q4 24 | $0.19 | $0.91 | ||
| Q3 24 | $-0.12 | $0.88 | ||
| Q2 24 | $-0.18 | $0.93 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $72.9M | $128.8M |
| Total DebtLower is stronger | $250.0M | — |
| Stockholders' EquityBook value | $52.4M | — |
| Total Assets | $399.5M | $648.9M |
| Debt / EquityLower = less leverage | 4.77× | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $128.8M | ||
| Q4 25 | $72.9M | $196.6M | ||
| Q3 25 | $74.3M | $237.6M | ||
| Q2 25 | $53.0M | $227.9M | ||
| Q1 25 | $66.7M | $251.4M | ||
| Q4 24 | $47.2M | $315.9M | ||
| Q3 24 | $72.6M | $84.0M | ||
| Q2 24 | $71.0M | $96.7M |
| Q1 26 | — | — | ||
| Q4 25 | $250.0M | $1.2B | ||
| Q3 25 | $347.2M | — | ||
| Q2 25 | $250.6M | — | ||
| Q1 25 | $256.9M | — | ||
| Q4 24 | $262.7M | $1.2B | ||
| Q3 24 | $230.7M | — | ||
| Q2 24 | $236.3M | — |
| Q1 26 | — | — | ||
| Q4 25 | $52.4M | $-736.8M | ||
| Q3 25 | $47.0M | $-702.6M | ||
| Q2 25 | $49.7M | $-686.0M | ||
| Q1 25 | $56.5M | $-715.0M | ||
| Q4 24 | $69.7M | $-675.6M | ||
| Q3 24 | $58.0M | $-447.5M | ||
| Q2 24 | $58.5M | $-437.5M |
| Q1 26 | — | $648.9M | ||
| Q4 25 | $399.5M | $693.4M | ||
| Q3 25 | $363.1M | $721.0M | ||
| Q2 25 | $345.0M | $708.3M | ||
| Q1 25 | $364.2M | $696.8M | ||
| Q4 24 | $389.0M | $716.2M | ||
| Q3 24 | $351.5M | $484.8M | ||
| Q2 24 | $306.6M | $451.8M |
| Q1 26 | — | — | ||
| Q4 25 | 4.77× | — | ||
| Q3 25 | 7.39× | — | ||
| Q2 25 | 5.05× | — | ||
| Q1 25 | 4.55× | — | ||
| Q4 24 | 3.77× | — | ||
| Q3 24 | 3.98× | — | ||
| Q2 24 | 4.04× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $8.4M | — |
| Free Cash FlowOCF − Capex | $8.1M | — |
| FCF MarginFCF / Revenue | 9.1% | — |
| Capex IntensityCapex / Revenue | 0.4% | — |
| Cash ConversionOCF / Net Profit | 1.27× | — |
| TTM Free Cash FlowTrailing 4 quarters | $43.0M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $8.4M | $57.3M | ||
| Q3 25 | $16.6M | $63.9M | ||
| Q2 25 | $-803.0K | $6.6M | ||
| Q1 25 | $19.7M | $25.3M | ||
| Q4 24 | $-17.8M | $7.7M | ||
| Q3 24 | $3.0M | $69.0M | ||
| Q2 24 | $-2.7M | $36.2M |
| Q1 26 | — | — | ||
| Q4 25 | $8.1M | $34.5M | ||
| Q3 25 | $16.4M | $61.7M | ||
| Q2 25 | $-969.0K | $-7.8M | ||
| Q1 25 | $19.5M | $17.3M | ||
| Q4 24 | $-18.3M | $-8.6M | ||
| Q3 24 | $2.3M | $54.9M | ||
| Q2 24 | $-3.1M | $25.9M |
| Q1 26 | — | — | ||
| Q4 25 | 9.1% | 19.6% | ||
| Q3 25 | 22.9% | 35.1% | ||
| Q2 25 | -1.5% | -4.5% | ||
| Q1 25 | 40.8% | 10.1% | ||
| Q4 24 | -27.4% | -5.3% | ||
| Q3 24 | 4.8% | 33.8% | ||
| Q2 24 | -6.3% | 16.6% |
| Q1 26 | — | — | ||
| Q4 25 | 0.4% | 13.0% | ||
| Q3 25 | 0.3% | 1.3% | ||
| Q2 25 | 0.3% | 8.2% | ||
| Q1 25 | 0.4% | 4.7% | ||
| Q4 24 | 0.8% | 10.1% | ||
| Q3 24 | 1.2% | 8.7% | ||
| Q2 24 | 0.7% | 6.6% |
| Q1 26 | — | — | ||
| Q4 25 | 1.27× | 2.14× | ||
| Q3 25 | 16.26× | 2.24× | ||
| Q2 25 | -0.16× | 0.25× | ||
| Q1 25 | — | 0.27× | ||
| Q4 24 | -2.62× | 0.29× | ||
| Q3 24 | — | 2.68× | ||
| Q2 24 | — | 1.32× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
HROW
Segment breakdown not available.
WING
| Royalty revenue, franchise fees and other | $87.5M | 48% |
| Advertising fees | $63.3M | 34% |
| Company-owned restaurant sales | $33.0M | 18% |
